These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30343299)

  • 1. Dialysate Calcium Concentration below 3.0 mEq/L Is Not Associated with Improved Outcomes in the Japanese Dialysis Outcomes and Practice Patterns Study.
    Iseki K; Henn LL; Nomura T; Kanda E; Tsuruya K; Hirakata H; Port FK; Pisoni RL; Tentori F; Robinson BM
    Nephron; 2018; 140(4):240-248. PubMed ID: 30343299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineral bone disorder and its management among hemodialysis patients in the Gulf Cooperation Council: Initial findings from the dialysis outcomes and practice patterns study (2012-2015).
    Al Salmi I; AlRukhaimi M; AlSahow A; Shaheen FA; Al-Ghamdi SM; AlAli F; AlGhareeb S; Al Maimani Y; AlGhonaim M; Bieber B; Tentori F; Pisoni RL;
    Saudi J Kidney Dis Transpl; 2016 Nov; 27(6 Suppl 1):62-80. PubMed ID: 27991480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Hecking M; Karaboyas A; Saran R; Sen A; Hörl WH; Pisoni RL; Robinson BM; Sunder-Plassmann G; Port FK
    Am J Kidney Dis; 2012 Feb; 59(2):238-48. PubMed ID: 21944663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study.
    Brunelli SM; Sibbel S; Do TP; Cooper K; Bradbury BD
    Am J Kidney Dis; 2015 Oct; 66(4):655-65. PubMed ID: 26015274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Karaboyas A; Zee J; Brunelli SM; Usvyat LA; Weiner DE; Maddux FW; Nissenson AR; Jadoul M; Locatelli F; Winkelmayer WC; Port FK; Robinson BM; Tentori F
    Am J Kidney Dis; 2017 Feb; 69(2):266-277. PubMed ID: 27866964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked improvement in bone metabolism parameters after increasing the dialysate calcium concentration from 2.5 to 3 mEq/L in nonhypercalcemic hemodialysis patients.
    Molina Vila P; Sánchez Pérez P; Garrigós Almerich E; Peris Domingo A
    Hemodial Int; 2008 Jan; 12(1):73-9. PubMed ID: 18271845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of dialysate calcium concentration in hemodialysis.
    Toussaint N; Cooney P; Kerr PG
    Hemodial Int; 2006 Oct; 10(4):326-37. PubMed ID: 17014507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.
    Young EW; Albert JM; Satayathum S; Goodkin DA; Pisoni RL; Akiba T; Akizawa T; Kurokawa K; Bommer J; Piera L; Port FK
    Kidney Int; 2005 Mar; 67(3):1179-87. PubMed ID: 15698460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F; Karaboyas A; Robinson BM; Morgenstern H; Zhang J; Sen A; Ikizler TA; Rayner H; Fissell RB; Vanholder R; Tomo T; Port FK
    Am J Kidney Dis; 2013 Oct; 62(4):738-46. PubMed ID: 23707043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.
    Yamada S; Ueki K; Tokumoto M; Suehiro T; Kimura H; Taniguchi M; Fujimi S; Kitazono T; Tsuruya K
    Ther Apher Dial; 2016 Feb; 20(1):31-9. PubMed ID: 26482334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study.
    Lacson E; Wang W; Ma L; Passlick-Deetjen J
    Am J Kidney Dis; 2015 Dec; 66(6):1056-66. PubMed ID: 26190226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study.
    Kimata N; Albert JM; Akiba T; Yamazaki S; Kawaguchi T; Fukuhara S; Akizawa T; Saito A; Asano Y; Kurokawa K; Pisoni RL; Port FK
    Hemodial Int; 2007 Jul; 11(3):340-8. PubMed ID: 17576300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis.
    Block GA; Yusuf AA; Danese MD; Wirtz HS; Hu Y; Do TP; Cooper K; Gilbertson DT; Bradbury BD; Collins AJ
    BMC Nephrol; 2016 Nov; 17(1):166. PubMed ID: 27814753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the Achievement of Target Range CKD-MBD Markers and Mortality in Prevalent Hemodialysis Patients in Taiwan by Using the Kidney Disease: Improving Global Outcomes Clinical Guidelines.
    Liu Y; Lee WC; Cheng BC; Li LC; Lee CH; Chang WX; Chen JB
    Biomed Res Int; 2016; 2016():1523124. PubMed ID: 28003998
    [No Abstract]   [Full Text] [Related]  

  • 15. Detecting high-risk chronic kidney disease-mineral bone disorder phenotypes among patients on dialysis: a historical cohort study.
    Neri L; Kreuzberg U; Bellocchio F; Brancaccio D; Barbieri C; Canaud B; Stuard S; Ketteler M
    Nephrol Dial Transplant; 2019 Apr; 34(4):682-691. PubMed ID: 30165528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interdialytic Weight Gain: Trends, Predictors, and Associated Outcomes in the International Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Wong MM; McCullough KP; Bieber BA; Bommer J; Hecking M; Levin NW; McClellan WM; Pisoni RL; Saran R; Tentori F; Tomo T; Port FK; Robinson BM
    Am J Kidney Dis; 2017 Mar; 69(3):367-379. PubMed ID: 27866963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
    Hamano T; Oseto S; Fujii N; Ito T; Katayama M; Horio M; Imai E; Hori M
    Bone; 2005 May; 36(5):909-16. PubMed ID: 15794928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fragility Fractures in Hemodialysis Patients. The association with Ca concentrations of dialysate and CKD-MBD.].
    Kobari E; James J
    Clin Calcium; 2018; 28(8):1101-1106. PubMed ID: 30049920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients.
    Soohoo M; Feng M; Obi Y; Streja E; Rhee CM; Lau WL; Wang J; Ravel VA; Brunelli S; Kovesdy CP; Kalantar-Zadeh K
    Am J Nephrol; 2016; 43(2):85-96. PubMed ID: 26950688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.